Summary
Nazanin Zounemat Kermani is currently a data analyst at Data Scient Institute working on the PIONEER project https://prostate-pioneer.eu/. PIONEER is a European Network of Excellence for Big Data in Prostate Cancer, consisting of 32 partners across 9 countries.
She is now interested in the clinical and applicational aspects of machine learning, rooted in combining and analysing the patient records and various data modalities including omics data to enable better understanding of disease mechanisms.
Publications
Journals
Tiotiu A, Zounemat Kermani N, Badi Y, et al. , 2021, Sputum macrophage diversity and activation in asthma: role of severity and inflammatory phenotype, Allergy, Vol:76, ISSN:0105-4538, Pages:775-788
Abdel-Aziz MI, Brinkman P, Vijverberg SJH, et al. , 2021, Sputum microbiome profiles identify severe asthma phenotypes of relative stability at 12-18 months, Journal of Allergy and Clinical Immunology, Vol:147, ISSN:0091-6749, Pages:123-134
Kermani NZ, Saqi M, Agapow P, et al. , 2021, Type 2-low asthma phenotypes by integration of sputum transcriptomics and serum proteomics., Allergy, Vol:76, ISSN:0105-4538, Pages:380-383
Kermani NZ, Pavlidis S, Xie J, et al. , 2020, Instability of sputum molecular phenotypes in U-BIOPRED severe asthma, European Respiratory Journal, Vol:57, ISSN:0903-1936, Pages:1-5
Omar MI, Roobol MJ, Ribal MJ, et al. , 2020, Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research., Nat Rev Urol, Vol:17